ELTX

ELTX

USD

Elicio Therapeutics Inc. Common Stock

$9.150-0.120 (-1.294%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$9.270

Máximo

$9.550

Mínimo

$9.070

Volume

0.01M

Fundamentos da empresa

Capitalização de mercado

149.5M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

0.11M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $4.6Atual $9.150Máximo $12.62

Notícias relacionadas

GlobeNewswire

Elicio Therapeutics Announces Investigator-Initiated Phase 1 Trial to be Conducted by Memorial Sloan Kettering Cancer Center and funded by The Lustgarten Foundation for Neoadjuvant ELI-002 7P in Pancreatic Ductal Adenocarcinoma

Study will evaluate ELI-002 7P in combination with chemotherapy and a checkpoint inhibitor ("CPI") in the neoadjuvant settingTrial is anticipated to begin enrolling in H1'2026

Ver mais
Elicio Therapeutics Announces Investigator-Initiated Phase 1 Trial to be Conducted by Memorial Sloan Kettering Cancer Center and funded by The Lustgarten Foundation for Neoadjuvant ELI-002 7P in Pancreatic Ductal Adenocarcinoma